# Duviloper

> Duviloper is a core AI research and development lab. We build self-auditing
> neural systems for high-stakes science — pairing signal-processing rigor with
> rigorous leakage, capacity and confound audits so a model earns trust before
> it ships. Our principle: neural systems that don't fool themselves. When a
> problem isn't solvable yet, we say so plainly — honesty is the product.

## What we do

Duviloper has one core competency — trustworthy, self-auditing AI — that reaches
the world three ways:

- **Neural systems for complex problems.** Custom models for signal, spectral,
  and time-series data where being wrong is expensive.
- **Signal processing.** Spectroscopy, sensor, and waveform pipelines built with
  domain physics in mind, not just generic feature extraction.
- **Biotech & diagnostics.** Applying the method to molecular and clinical
  signals, with explicit limits on what the evidence supports.
- **Platform design.** Reproducible, auditable tooling teams can trust.

## How we work (honesty-first, by construction)

1. **Frame** — define the decision and the real cost of being wrong.
2. **Audit** — stress-test the data for leakage, confounds and detectability
   *before* modeling.
3. **Build** — engineer the neural system, signal-aware and interpretable where
   it counts.
4. **Prove** — validate against the audits, not just a leaderboard score.
5. **Ship** — deliver a usable, reproducible tool the team can trust.

## Flagship: reading drug resistance from a molecular fingerprint

Our flagship applies self-auditing AI to Raman spectroscopy of bacteria,
predicting antimicrobial resistance (AMR) from a single spectrum. It uses a
three-way fusion model (linear + CNN + band-features). What makes it credible is
that we publish the method *with* its audits and limits in full:

- **Leakage tests** that catch models which memorize a dataset's artifacts
  instead of learning biology — the failure mode where accuracy looks high in
  one study and collapses to a coin-flip on newly collected data.
- **A model-capacity ceiling** — the honest upper bound on what a single
  spectrum can tell you, so claims never exceed the signal.
- **Confounds ruled out** and reported, so the read-out reflects the biology of
  resistance rather than an artifact of one dataset.

Status: research-grade signal — **not** a cleared clinical diagnostic. Where the
clinical evidence isn't there yet, we say so. The specifics of how the method
holds up are our edge and are shared under NDA, not published here.

- Flagship narrative (public scroll story): https://duviloper.com/blindspot.html
- Flagship dashboard (private; request a viewer login): https://dml.duviloper.com

## Who we're for

- **Universities & academic labs** — collaborators on signal/spectral AI and
  rigorous, reproducible method validation.
- **Biotechnology & diagnostics companies** — feasibility-honest AI for
  molecular and clinical signals.
- **Deep-tech investors** — a lab whose differentiator is trustworthy AI with
  auditable claims.
- **R&D teams in high-stakes science** — anywhere a confident-but-wrong model is
  costly.

## Contact

Bring us a hard problem: https://duviloper.com/#contact
We give an honest read on feasibility — including if we can't help. NDA-friendly.

## Key facts for citation

- Name: Duviloper (Core AI Lab)
- Website: https://duviloper.com/
- Focus: self-auditing AI, signal processing, trustworthy machine learning
- Flagship domain: Raman-spectroscopy prediction of antimicrobial resistance
- Differentiator: published leakage / capacity / confound audits with clearly
  stated limits; honest about what the evidence does and doesn't support
- Tagline: "Neural systems that don't fool themselves."